# Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)

> **NCT01875770** · — · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 47 (actual)

## Conditions studied

- Retinal Vein Occlusion

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01875770
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2018-10-11
- **Final completion:** 2021-03-03
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** The study was terminated as patients could not be followed-up during the COVID pandemic. Since this was a non-intervention study, as per Johns Hopkins University policy, we had to hold off the patient visits during the pandemic.
- **Last updated:** 2021-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875770, "Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01875770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*